Cabaletta Bio (CABA) Enterprise Value (2018 - 2025)
Cabaletta Bio's quarterly Enterprise Value came in at -$133.6 million in Q4 2025, up 18.52% year-on-year from -$112.7 million in Q4 2024, and up 16.46% quarter-over-quarter from -$159.9 million in Q3 2025.
Cabaletta Bio has reported Enterprise Value for 8 years, with the latest figure at -$133.6 million in Q4 2025.
- For the quarter ending Q4 2025, Enterprise Value rose 18.52% year-over-year to -$133.6 million; the trailing twelve-month figure through Dec 2025 stood at -$133.6 million (up 18.52% YoY), and the FY2025 full-year result was -$133.6 million, up 18.52% from the prior year.
- Enterprise Value for Q4 2025 stood at -$133.6 million, up from -$159.9 million in the prior quarter.
- The five-year high for Enterprise Value was -$93.8 million in Q1 2023, with the low at -$272.4 million in Q1 2024.
- Average Enterprise Value over 5 years is -$161.5 million, with a median of -$152.7 million recorded in 2022.
- Year-over-year, Enterprise Value tumbled 190.26% in 2024 and jumped 51.6% in 2025.
- Tracing CABA's Enterprise Value over 5 years: stood at -$122.2 million in 2021, then increased by 12.83% to -$106.5 million in 2022, then sank by 126.42% to -$241.2 million in 2023, then surged by 32.04% to -$164.0 million in 2024, then rose by 18.52% to -$133.6 million in 2025.
- The last three Enterprise Value figures came in at -$133.6 million (Q4 2025), -$159.9 million (Q3 2025), and -$194.7 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.32 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -32.30 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -286.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | -61.46 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.77 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -7.25 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -18.44 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -8.75 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -3.01 Bn |
| 10 | Cabaletta Bio | 194.84 Mn | 61.24 Mn | - | -133.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -133.60 Mn |
| Sep 30, 2025 | -159.93 Mn |
| Jun 30, 2025 | -194.68 Mn |
| Mar 31, 2025 | -131.83 Mn |
| Dec 31, 2024 | -163.96 Mn |
| Sep 30, 2024 | -195.42 Mn |
| Jun 30, 2024 | -227.84 Mn |
| Mar 31, 2024 | -272.40 Mn |
| Dec 31, 2023 | -241.25 Mn |
| Sep 30, 2023 | -213.28 Mn |
| Jun 30, 2023 | -224.58 Mn |
| Mar 31, 2023 | -93.85 Mn |
| Dec 31, 2022 | -106.55 Mn |
| Sep 30, 2022 | -110.63 Mn |
| Jun 30, 2022 | -146.44 Mn |
| Mar 31, 2022 | -158.87 Mn |
| Dec 31, 2021 | -122.22 Mn |
| Sep 30, 2021 | -120.26 Mn |
| Jun 30, 2021 | -106.12 Mn |
| Mar 31, 2021 | -106.78 Mn |
| Dec 31, 2020 | -108.66 Mn |
| Sep 30, 2020 | -116.74 Mn |
| Jun 30, 2020 | -130.88 Mn |
| Mar 31, 2020 | -131.00 Mn |
| Dec 31, 2019 | -136.20 Mn |
| Sep 30, 2019 | -71.04 Mn |
| Dec 31, 2018 | -33.02 Mn |